A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen
- Publication date
- 1 January 2013
- Publisher
- 'Springer Science and Business Media LLC'